insider trading  ross thomas w sr  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  ross thomas w sr select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing purchase  pm valeant pharmaceuticals international inc vrx ross thomas w srdirector    direct view purchase  pm valeant pharmaceuticals international inc vrx ross thomas w srdirector    direct view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana valeant pharmaceuticals international inc vrx ross thomas w srdirector   direct view option award  pm nana valeant pharmaceuticals international inc vrx ross thomas w srdirector   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  thomas w ross  wikipedia thomas w ross from wikipedia the free encyclopedia jump to navigation search for other people named thomas ross see thomas ross disambiguation thomas w ross president of the university of north carolina in office january   – january   preceded by erskine bowles succeeded by margaret spellings thomas w ross th president of davidson college in office – preceded by robert f vagt succeeded by carol quillen personal details born  june   age  greensboro north carolina us political party democratic alma mater davidson college university of north carolina chapel hill thomas warren ross sr is an american public official who served as the president of the university of north carolina system from  to  he succeeded erskine bowles on january   formerly he was president of davidson college a private north carolina liberal arts college from august   to january   ross a native of greensboro north carolina graduated from davidson in  as did his father in  and his children in  and  in  he graduated with honors from the university of north carolina school of law ross became an attorney chief of staff to congressman robin britt a state superior court judge for  years director of the north carolina administrative office of the courts and executive director of the z smith reynolds foundation in winstonsalem – he is a former chairman of the unc greensboro board of trustees ross is the recipient of the william rehnquist award for judicial excellence the boy scouts of america distinguished eagle scout award governing magazines national public official of the year award one of ten  and the order of the long leaf pine on august   ross was elected president of the university of north carolina system on june th  ross delivered the commencement address at the north carolina school of science and mathematics a unc member instititution in an article on the washington post on may  as of july   ross will become the president of the volcker alliance a nonpartisan organization aimed at rebuilding public trust in government that was founded by paul volcker ross named the first terry sanford distinguished fellow at duke university’s sanford school of public policy in  referencesedit  httpwwwdavidsoneducmsxxml  news  observer davidson president to lead unc system  news  observer its official ross is the new unc president  unc press release ross elected president of the university of north carolina  sending off class of  to lead and help others north carolina school of science and mathematics ncssm retrieved  june    news  observer  unc president emeritus ross named sanford fellow at duke  duke university sanford school of public policy sanforddukeedu retrieved   winstonsalem journal article davidson college alum returns as its new president davidson press release official biography distinguished alumnus award citation academic offices preceded by erskine bowles president of the university of north carolina system – succeeded by margaret spellings academic offices preceded by robert f vagt presidents of davidson college – succeeded by carol quillen v t e presidents of the university of north carolina system for university of north carolina presidents prior to consolidation in  see  consolidated university graham carmichael gray purks friday friday unc system friday spangler broad bowles ross spellings italics indicate acting president v t e davidson college presidents morrison  williamson  lacy  kirkpatrick  mcphail  blake  hepburn  mckinnon  shearer  smith  martin  lingle  cunningham  martin  spencer  kuykendall  vagt  ross  quillen present list excludes interim or acting presidents retrieved from httpsenwikipediaorgwindexphptitlethomaswrossoldid categories  birthsamerican university and college presidentsdavidson college alumnidistinguished eagle scoutsliving peoplenorth carolina lawyersnorth carolina state court judgespresidents of the university of north carolina systemuniversity of north carolina at chapel hill alumnipresidents of davidson college navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view   thomas w sr ross  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors thomas w sr ross check out list of companies and businesses related to thomas w sr ross find out thomas w sr ross address and contact details view other people related to thomas w sr ross  coworkers colleagues companions etc address  somerset corporate boulevard bridgewater  nj companies related to thomas w sr ross cikcompany namepositioncompany addressvaleant pharmaceuticals international incdirector  st elzear blvd west laval quebec hl a thomas w sr ross on the web persons related to thomas w sr ross  valeant pharmaceuticals international incnamepositioncitychristina ackermannevp and general counsel bridgewaterwilliam a ackmannew yorkthomas appioevp company group chairman bridgewaterrobert roswell chaionnevp clo general counsel mississaugarobert roswell chaionnevp gc  corp sec mississaugarobert roswell chaionnevp gen couns and corp sec montrealrobert roswell chaionnmontrealrobert roswell chaionnevp gen couns  corp sec montrealrobert roswell chaionnmontrealrobert roswell chaionnevp gen couns  corp sec lavalrobert roswell chaionnevp gen couns  corp secy lavalmichel chouinardmississaugamichel chouinardcoo biovail labs intl srl mississaugamichel chouinardcoo biovail labsintl srl worthing christ churchmichel chouinardcoo biovail labs intl srl mississaugamichel chouinardcoo biovail labs intl srl mississaugaschutter richard u dedirector palo altosilva rajiv depresident  coo mississaugasilva rajiv depresident  coo spec pharma mississaugasilva rajiv depresidentvpiicoospecpharma mississaugasilva rajiv depresident  coo mississaugasilva rajiv depresident and coo montrealsilva rajiv depresident  coo montrealmark andrew durhamsenior vp hr  shared svs mississaugamark andrew durhamsvp hr  shared services mississaugamark andrew durhamsvp hr  shared services mississaugamark andrew durhamsvp human resources mississaugamark andrew durhamsvp human resources mississaugasam eldessoukysvp chief accounting officer princetonfredric n eshelmandirector wilmingtonronald harold farmerdirector mississaugaronald harold farmerdirector montrealronald harold farmerdirector lavalhans christian fibigermississaugahans christian fibigerchief scientific officer mississaugahans christian fibigerchief scientific officer mississaugahans christian fibigerchief scientific officer mississaugahans christian fibigerchief scientific officer mississaugastephen fraidinnew yorkgilbert godinexecutive vicepresident  coo mississaugagilbert godinevp  coo mississaugagilbert godinevp  coo mississaugacolleen a gogginsdirector new brunswickcolleen a gogginsdirector bridgewaterserge gouinmississaugaserge gouindirector mississaugagregory david gubitzmississaugagregory david gubitzsenior vice president  gc mississaugagregory david gubitzsvp corp devel  gc mississaugadavid robert haledirector san franciscosusan hallglobal head of rd mississaugasusan hallglobal head of rd montrealsusan hallglobal head of rd montrealsusan hallglobal head of rd lavaljason david hansonevp company group chairman montrealfred hassandirector lavalpaul herendeenevp and cfo rockawaywilliam d humphriesevp company group chairman alpharettarobert a ingramdirector robert alexander ingramdirector mississaugarobert alexander ingramdirector mississaugarobert alexander ingramdirector mississaugarobert alexander ingramdirector montrealrobert alexander ingramdirector lavaldebora jornevp company group chairman bridgewaterargeris n karabelasdirector san diegosarah b kavanaghdirector lavalari kellenevp company group chairman bridgewaterari kellenevp company group chairman bridgewaterari kellenevp company group chairman bridgewaterlaizer kornwasserevp company group chairman franklin lakeslaizer kornwasserevp company group chairman montreallaizer kornwasserevp company group chairman lavallaizer kornwasserevp company group chairman bridgewaterlaizer kornwasserbridgewaterlaizer kornwasserevp company group chairman bridgewaterlaizer kornwasserevp company group chairman bridgewaterdavid h laidleydirector mississaugadavid h laidleydirector mississaugajohn spencer lanthiermississaugajohn spencer lanthierdirector mississaugaphilip walden loberg jrevp interim cfo mississaugaphilip walden loberg jrevp interim cfo mississaugaanders lonnerdirector aliso viejoanders lonnerdirector bridgewaterrichard kevin mastersonprescoovaleant intbbsrl mississaugarichard kevin mastersonpres  coo valeant int bb mississaugarichard kevin mastersonpres  coo valeant intl bb montrealchristine mayersvp bta pharmaceuticals inc mississaugachristine mayersvp bta pharmaceuticals inc mississaugachristine mayersvp bta pharmaceuticals inc mississaugakyriazi theo melasdirector kyriazi theo melasdirector mississaugakyriazi theo melasdirector mississaugakyriazi theo melasdirector montrealkyriazi theo melasdirector lavalpavel mirovskyevp pres  gm valeant emena lavalg mason morfitdirector san franciscomargaret jean mulliganmississaugamargaret jean mulligansvp  cfo mississaugamargaret jean mulliganevp cfo mississaugajoseph c papachairman  ceo coronamark w parrishdirector mississaugamark w parrishdirector mississaugalaurence e pauldirector mississaugalaurence e pauldirector mississaugalaurence e pauldirector mississaugalaurence e pauldirector mississaugalaurence e pauldirector mississaugalaurence e pauldirector montrealjohn paulsondirector new yorkj michael pearsonchief executive officer aliso viejoj michael pearsonmississaugaj michael pearsonchief executive officer mississaugaj michael pearsonchief executive officer mississaugaj michael pearsonchief executive officer mississaugaj michael pearsonchief executive officer montrealj michael pearsonmontrealj michael pearsonchief executive officer lavalpershing square capital management lpdirector new yorkfrank pottermississaugafrank potterdirector mississaugarobert n powerdirector madisonrobert n powermississaugarobert n powerdirector mississaugarobert n powerdirector mississaugarobert n powerdirector montrealrobert n powerdirector lavalrobert n powermontrealnorma ann provenciodirector covinanorma ann provenciodirector mississauganorma ann provenciodirector mississauganorma ann provenciodirector mississauganorma ann provenciodirector montrealnorma ann provenciodirector lavalps management gp llcnew yorkrussel c robertsondirector bridgewaterrobert l rosielloevp corp dev  strategy bridgewaterthomas w sr rossdirector bridgewaterhoward bradley schillerchairman and ceo mississaugahoward bradley schillerevp and cfo mississaugahoward bradley schillerevp and cfo montrealhoward bradley schillerevp and cfo montrealhoward bradley schillerevp and cfo lavalhoward bradley schillerchief financial officer lavallloyd mitchell segalmississaugalloyd mitchell segaldirector mississaugalloyd mitchell segaldirector mississaugalloyd mitchell segaldirector mississaugalloyd mitchell segaldirector montreallloyd mitchell segaldirector lavaldouglas john paul squiresmississaugadouglas john paul squiresdirector mississaugakatharine berghuis stevensondirector bramptonkatharine berghuis stevensondirector montrealkatharine berghuis stevensondirector lavalkatharine berghuis stevensondirector lavalkatharine berghuis stevensondirector lavalkatharine berghuis stevensondirector mississaugakatharine berghuis stevensondirector mississaugakatharine berghuis stevensondirector mississaugabrian m stolzevp administration  chco mississaugabrian m stolzevp administration and chco mississaugabrian m stolzevp administration and chco montrealbrian m stolzevp administration  chco montrealbrian m stolzevp administration and chco montrealbrian m stolzevp administration and chco lavallouis randall tullmississaugalouis randall tulldirector mississaugajeffrey w ubbendirector jeffrey w ubbendirector san franciscova partners i llcsan franciscova partners i llcsan franciscovalueact capital management lpsan franciscovalueact capital management lpsan franciscovalueact capital management llcsan franciscovalueact capital management llcsan franciscovalueact capital master fund lpsan franciscovalueact capital master fund lpsan franciscovalueact coinvest master fund lpsan franciscovalueact coinvest master fund lpsan franciscovalueact holdings gp llcsan franciscovalueact holdings gp llcsan franciscovalueact holdings lpdirector san franciscovalueact holdings lpdirector san franciscoevery michael robert vanmississaugaevery michael robert vandirector mississaugaevery michael robert vandirector mississaugaevery michael robert vandirector mississaugaamy b wechslerdirector bridgewaterdaniel mark wechslerevo co grp chmn eye health lavalryan weldonevp company group chairman montrealryan weldonevp company group chairman lavalryan weldonevp company group chairman lavalwilliam mcdowall wellschief executive officer mississaugawilliam mcdowall wellschief executive officer mississaugawilliam mcdowall wellsdirector mississaugawilliam mcdowall wellsdirector mississaugaanne clem whitakerevp company group chairman durham microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft valeant pharmaceuticals appoints thomas w ross sr lead independent director valeant pharmaceuticals appoints thomas w ross sr lead independent director news provided by valeant pharmaceuticals international inc jun    et share this article all eleven director nominees elected to the board at annual meeting of shareholders laval quebec june   prnewswire  valeant pharmaceuticals international inc nyse vrx and tsx vrx today announced that its board of directors has appointed thomas w ross sr as its lead independent director  mr ross who has been a member of valeants board since march   serves on the boards nominating and corporate governance committee and is chairperson of its conduct and compliance committee i am delighted that tom will serve valeant in this important role said joseph c papa chairman and chief executive officer toms contributions to the board have been invaluable and i believe the company will continue to benefit greatly from his insights and expertise as we move valeant forward i am pleased to expand my service to valeant as its lead independent director said mr ross the board is very pleased with our new ceo and chairman mr papa and we all share with joe and the management team a deep commitment to working with valeants strong assets and personnel to launch a new chapter in the companys history following todays annual meeting of shareholders three new independent directors were elected to valeants board including dr argeris n karabelas russel c robertson and dr amy b wechsler eight directors were reelected  mr ross william a ackman dr frederic eshelman stephen fraidin d robert hale robert a ingram robert n power and joseph c papa  in the past year valeant has significantly refreshed its board adding nine new directors and expanding the number of independent directors to  out of  the detailed results of the vote for the election of directors are set out below  name for withheld broker nonvotes william a ackman    dr frederic n eshelman    stephen fraidin    d robert hale    robert a ingram    dr argeris jerry n karabelas    joseph c papa    robert n power    russel c robertson    thomas w ross sr    amy b wechsler md    at the annual meeting shareholders also approved the nonbinding advisory vote on named executive officer compensation as disclosed in the proxy statement and appointed pricewaterhousecoopers llp as the companys independent registered public accounting firm until the close of the companys  annual meeting of shareholders the final vote tabulation on all matters voted on at todays meeting will be reported to the us securities and exchange commission on a current report on form k and such report will be made available on the companys web site at wwwvaleantcom thomas w ross sr is president emeritus of the campus university of north carolina having served as president from   he currently serves as the sanford distinguished fellow in public policy at the duke university sanford school of public policy and as a professor of public law and government at the unc chapel hill school of government  on july   mr ross will assume the role of president of the volker alliance in new york prior to becoming president of the unc system mr ross served as president of davidson college executive director of the z smith reynolds foundation director of the north carolina administrative office of the courts a superior court judge chief of staff to a u s congressman a member of a greensboro nc law firm and as an assistant professor of public law and government at uncchapel hills school of government  mr ross holds a bachelors degree in political science from davidson college and graduated with honors from the uncchapel hill school of law  mr ross currently serves several boards and has received numerous awards and accolades for his public service and professional achievements about valeant valeant pharmaceuticals international inc nysetsxvrx is a multinational specialty pharmaceutical company that develops manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology gastrointestinal disorders eye health neurology and branded generics more information about valeant can be found at wwwvaleantcom contact information laurie w little laurielittlevaleantcom or elif mcdonald elifmcdonaldvaleantcom     toll free mediarenée sotoor chris kittredgejared levysard verbinnen  co logo  httpphotosprnewswirecomprnhlalogo   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesvaleantpharmaceuticalsappointsthomaswrosssrleadindependentdirectorhtml source valeant pharmaceuticals international inc related links httpwwwvaleantcom jun    et preview valeant pharmaceuticals announces launch of new preservision® areds  formula  multivitamin jun    et preview valeant to participate in fda advisory committee meeting on july  my news release contains wide tables view fullscreen also from this source jul    et valeant announces us launch of siliq™ brodalumab injection jul    et valeant agrees to sell obagi medical products business explore more news releases in similar topics biotechnology health care  hospitals medical pharmaceuticals pharmaceuticals personnel announcements you just read valeant pharmaceuticals appoints thomas w ross sr lead independent director news provided by valeant pharmaceuticals international inc jun    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top vz log in for events urbn urbn syna ll hp log in for events alks cvrr cvrr esnd find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  am et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  unavailable  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries this feature is temporarily unavailable copyright – fmr llc  all rights reserved  terms of use privacy security site map  vrx stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsvrx valeant pharmaceuticals international inc    as of am et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all adp stock jumps  in midday trade on reports of ackman stake marketwatch –  pm et  shares of automatic data processing inc adp jumped more than  in thursday afternoon trade following a bloomberg news report that bill ackmans pershing square capital management had taken a stake in payroll company adp bloomberg cited people familiar with the matter indicating that ackman had recently bought shares in adp and that he may increase his position the report didnt specify the size of the activist investors position briefvaleant announces us launch of siliq injection reuters –  am et  astrazeneca plc azn  valeant announces us launch of siliq injection  valeant says that its dermatology unit will be renamed ortho dermatologics effective immediately  valeant says under new senior leadership team lead by bill humphries executive vice president and company group chairman ortho dermatologics valeant announces us launch of siliq™ brodalumab injection pr newswire –  am et  dermatology unit is rebranded ortho dermatologics laval quebec july    valeant pharmaceuticals international inc vrx today announced the launch of siliq injection during the summer american academy of dermatology  meeting taking place in new york from july   siliq a monoclonal antibody that targets the il receptor a is indicated for the treatment of moderatetosevere p daily technical summary reports on healthcare stocks  valeant pharma palatin technologies amag pharma and idexx labs pr newswire –  am et  new york july   if you want a stock review on vrx ptn amag or idxx then come over to httpdailystocktrackercomregister and sign up for your free customized report today httpdailystocktrackercomregister valeant pharma  laval canada headquartered valeant pharmaceuticals international incs vrx shares recorded a trading volume of  million shares last friday us democrats take aim at big companies in economic blueprint reuters –  am et  us democrats are unveiling an economic platform on monday that they call a better deal for working americans by announcing plans to address unfair market competition rising pharmaceutical costs and stagnant wages briefprogenics pharmaceuticals says received notification of a paragraph iv certification for certain patents for subcutaneous relistor reuters –  pm et  progenics pharmaceuticals inc pgnx  progenics pharmaceuticals pgnx  on july  received notification of a paragraph iv certification for certain patents for subcutaneous relistor  progenics pharma  certification resulted from filing by par sterile products of anda challenging patents for subcutaneous relistor  sec filing valeant is meeting its debt goals but core business is still struggling marketwatch –  am et  credit analysts are more cautious on the company than equity analysts valeant international pharmaceutical inc says its on track with its  billion debtreduction goal after a series of asset sales leading analysts to refocus attention on the companys core business with some mixed results the montrealbased drug company which is still recovering from an accounting and drug pricing scandal that cost billionaire investor bill ackman  billion has unveiled a series valeant agrees to sell obagi medical products for  million in cash marketwatch –  pm et  valeant pharmaceuticals international inc vrx said monday it has reached an agreement to sell its obagi medical products business to haitong international zhonghua finance acquisition fund i lp for  million in cash obagi is a specialty drug company that makes products aimed at premature skin aging skin damage and other skin problems that are mostly available from dermatologists plastic surgeons and medical spas the deal is expected to close in the second half and canada stockstsx rises as higher metal prices boost miners reuters –  am et   tsx up  points or  percent at   four of the tsxs  main groups move higher canadas main stock index rose on monday as mining shares tracked metal prices higher while shares of energy companies gained as oil prices edged up valeant shares up  premarket marketwatch –  am et  briefvaleant agrees to sell obagi medical products business reuters –  am et  valeant  valeant agrees to sell obagi medical products business valeant to use proceeds of obagi sale to repay term loan debt marketwatch –  am et  valeant agrees to sell obagi medical products for  mln in cash marketwatch –  am et  valeant agrees to sell obagi medical products business pr newswire –  am et  laval quebec july   valeant pharmaceuticals international inc vrx today announced that certain affiliates of the company have entered into an agreement to sell its obagi medical products business for  million in cash to haitong international zhonghua finance acquisition fund i lp limited partners of the fund include industry veterans in other geographic markets such as china reg briefvaleant announces redemption of about  mln senior notes reuters –  am et  valeant pharmaceuticals international inc vrx  valeant announces redemption of remaining approximately  million aggregate principal amount of its outstanding  senior notes due   valeant announces redemption of remaining approximately  million aggregate principal amount of its outstanding  senior notes due  valeant redeems  million of debt on track to meet or exceed  billion debt reduction goal marketwatch –  am et  valeant pharmaceuticals international inc vrx said thursday it is redeeming the roughly  million of outstanding  notes that mature in  using cash on hand as it continues to work to reduce its debt burden the troubled drug company which has come through an accounting scandal that led to the ouster of its ceo said it has now reduced its debt by more than  billion since the first quarter of  and is on track to meet its goal of paying down  billion in debt within  valeant shares up  premarket marketwatch –  am et  valeant says confident it can meet or exceed  bln debt reduction commitment early marketwatch –  am et  valeant to redeem remaining roughly  mln of senior notes that mature in  marketwatch –  am et  valeant announces redemption of remaining approximately  million aggregate principal amount of its outstanding  senior notes due  pr newswire –  am et  upon redemption valeants debt reduction will total more than  billion since the end of firstquarter  laval quebec july    valeant pharmaceuticals international inc vrx today announced that it will redeem the remaining approximately  million aggregate principal amount of its outstanding  senior notes due  cusip nos page page   next  todays and upcoming events aug  vrx to announce q earnings before market confirmed aug  vrx earnings conference call at  am listen past events last  days no events in the past  days data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe ross thomas w sr insider insider trades  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  ownership  insider trades  individual insiders insider trades of ross thomas w sr click on the column header to resort ascending ▲ or descending ▼ individual insider trades company relation last date ▼ type tran ownertype shares traded last price shares held valeant pharmaceuticals international inc director  form  acquisition non open market direct    valeant pharmaceuticals international inc director  form  buy direct    valeant pharmaceuticals international inc director  form  acquisition non open market direct    valeant pharmaceuticals international inc director  form  buy direct    valeant pharmaceuticals international inc director  form  acquisition non open market direct    highest rated articles of last week shareholders approve major structural change to top performing yatra attains leadership position in corporate travel with the miller heiman group selects calliduscloud datahug for pipeline tractor supply company reports second quarter results spectranetics announces fda approval of stellarex™ drugcoated balloon view all highest rated most rated stocks of last week rated stocks for nasdaq nyse and amex symbol  ratings consensus aapl  bullish of  ratings rate it fb  bullish of  ratings rate it msft  bullish of  ratings rate it tsla  bullish of  ratings rate it goog  bullish of  ratings rate it jpm  bullish of  ratings rate it gm  bullish of  ratings rate it nvda  bullish of  ratings rate it bac  bullish of  ratings rate it intc  bullish of  ratings rate it more most rated stocks closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex ross thomas w sr  valeant pharma insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsross thomas w srvaleant pharma vrxdirectorranked  out of  insiders on tipranksross thomas w srs performanceprofitable transactions out of  profitable transactionsaverage returnaverage return per transactioneach transaction is measured over a  year months month period and compared to no benchmarksp sectorhow are insiders ranked most profitable insider tradestock valeant pharma vrxtransaction type informative buydates dec    todaygain see the latest stocks traded by insiders  ross thomas w srs trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction datevrxvaleant pharmadirectoruninformative buymay  success rate on stock out of  profitable transactions on vrxaverage profit on stockaverage return per transaction on vrx  track record showingall transactionsinformative transactionsdatetransactionamountno of sharesprice per shareprofitform  may   uninformative buy    na dec   informative buy k    jun   informative buy k    show moresee all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by thomas w ross sr is no longer serving in their position at university of north carolina system news home advertising board and executive moves energy health care hedge funds m  a private equity technology thomas w ross sr is no longer serving in their position at university of north carolina system email linkedin facebook google tweet reddit permalink jan    relsci data update board and executive moves background information thomas w ross sr » president at the volcker alliance career the volcker alliance university of north carolina system university of north carolina chapel hill  school of government boards valeant pharmaceuticals international inc rti international the university of north carolina at greensboro education university of north carolina  chapel hill  school of law davidson college unc school of law in the news movers  shakers july  moelis hires from bofa scotiabank july    •  the deal pipeline boardex movers healthcare sector highlights july    •  the deal pipeline beleaguered valeant appoints lead independent director june    •  the deal pipeline thomas w ross sr » president at the volcker alliance career • the volcker alliance • university of north carolina system • university of north carolina chapel hill  school of government boards • valeant pharmaceuticals international inc • rti international • the university of north carolina at greensboro education • university of north carolina  chapel hill  school of law • davidson college • unc school of law in the news movers  shakers july  moelis hires from bofa scotiabank  july    •  the deal pipeline boardex movers healthcare sector highlights  july    •  the deal pipeline beleaguered valeant appoints lead independent director  june    •  the deal pipeline university of north carolina system » in the news sme international awards gala recognizes celebrates manufacturing leaders and researchers may    •  pr newswire collegebound teens face finals  in picking a school may    •  the washington post st thomas benjamin april    •  south florida sunsentinel university of north carolina system » in the news sme international awards gala recognizes celebrates manufacturing leaders and researchers  may    •  pr newswire collegebound teens face finals  in picking a school  may    •  the washington post st thomas benjamin  april    •  south florida sunsentinel youve found a premium relsci pro feature connect to individuals and organizations in this story upgrade to relsci pro to easily sync your contacts and see how you can reach the people and organizations featured in this article start my free trial ➤ still not convinced check out our full listing of features here not now are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤